🟢 Rezolute is trading 6.6% up in after-hours trading after announcing full Phase 3 upLIFT enrollment

Rezolute is trading at $4.51, up 6.62%, after-hours following its announcement that the Phase 3 upLIFT study of ersodetug is fully enrolled.

• The company announced the milestone at 4:05 p.m. ET on October 14; topline results are expected in mid-December 2026.
• The release did not state that the announcement caused the after-hours move.
• Broader markets were under pressure after hotter-than-expected inflation; Reuters reported the Nasdaq fell 1.88% on October 14.